The collaborative efforts of health technology assessment (HTA) bodies in the Nordic region have taken a significant step forward with the formation of the Joint Nordic HTA-Bodies (JNHB). Over the past year, Denmark and Iceland joined the FINOSE collaboration, which initially included Finland, Norway, and Sweden. This expansion has led to the rebranding of the alliance to better reflect its broader scope and inclusivity.
To celebrate this new era of Nordic cooperation, JNHB has invited industry associations, decision-makers, and stakeholders to a joint meeting to officially launch the collaboration. The event will unveil the new JNHB website, www.jnhtabodies.org, and introduce supporting documents that detail the joint assessment process, guidance for Health Technology Developers, and requirements for application and submission dossiers. These resources aim to enhance transparency and provide clear guidance for companies engaging with JNHB.
New JNHB Website Enhances Transparency and Collaboration in Nordic Health Technology Assessment
The newly launched website serves as a central hub for information about the Joint Nordic HTA-Bodies collaboration. It includes comprehensive details on the joint assessment process, health economic methods, and other critical guidance to support Health Technology Developers. By making these processes and methods accessible, JNHB ensures a transparent and straightforward engagement for companies.
In a move to further strengthen Nordic collaborations, JNHB has entered into a partnership with the negotiation bodies within the Nordic Pharmaceutical Forum. This collaboration aims to clarify the link between health technology assessment and negotiations on a Nordic level, streamlining processes and fostering greater cooperation.
JNHB Team Outlines Future Role Ahead of 2025 Health Technology Assessment Regulation Implementation
During the launch event, the JNHB team shared their initial perspectives on the anticipated role of JNHB following the implementation of the health technology assessment regulation in January 2025. This regulation is expected to further integrate and streamline health technology assessment processes across the Nordic countries, enhancing efficiency and collaboration.
FINOSE began as a grassroots initiative by health technology assessment authorities in Finland, Norway, and Sweden, officially launched in Stockholm in 2018. The collaboration expanded to include Denmark in 2023 and Iceland in 2024, leading to the formation of JNHB. The foundation of this collaboration is detailed in a Memorandum of Understanding signed in April 2024 by the participating HTA bodies: the Danish Medicines Council (DMC), the Finnish Medicines Agency (Fimea), LandspÃtali – The National University Hospital of Iceland, the Norwegian Medical Products Agency (NOMA), and the Dental and Pharmaceutical Benefits Agency (TLV) in Sweden.
Resource: Joint Nordic HTA-Bodies, June 03, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
